Hot Mandate: Big Pharma Venture Arm Interested in AI for Drug Discovery and Development

12 Apr

Established in 2014, the venture arm of a large pharmaceutical company focuses on novel therapeutics R&D. The firm is seeking for the partnership in new technique platforms, new targets in the therapeutic areas of oncology, IO, neuroscience, diabetes and other areas with unmet medical needs. The firm is also interested in AI for drug discovery and development.

The firm is especially interested in Antibody therapeutics including new structure antibodies, Gene Therapy, Car-T, Targeted Therapy, oncolytic virus therapy, and rare disease.

The firm has no specific requirements for the company and management team.

If you are interested in more information about this investor and other investors tracked by LSN, please email 4dmeetsai@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: